Rheumatic fever‐associated B cell alloantigens as identified by monoclonal antibodies
Abstract
Mice immunized with B lymphocytes obtained from patients who had had well-documented rheumatic fever in the past yielded 2 monoclonal antibodies, termed 83S19.23 and 256S10, which identified certain alloantigens present on the B cells of these patients. The frequency of the B cell marker detected by clone 83S19.23 in rheumatic fever patients was found to be 59%, 77%, and 74% in India, New Mexico, and New York, respectively. Monoclonal antibody 256S10 identified 75% of those rheumatic fever patients who were nonreactive to clone 83S19.23. Thus, the 2 antibodies identify approximately 92% of all rheumatic fever patients and suggest the presence of a diallelic genetic marker for susceptibility to rheumatic fever.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A high frequency of in vitro elevated D8/17 binding to B lymphocytes has been found as a susceptibility marker for developing ARF more than PSRA.
“A high frequency of in vitro elevated D8/17 binding to B lymphocytes has been found as a susceptibility marker for developing ARF more than PSRA [7, 8, 24].”
Cited by
Sorted by citations
Jansen, T. L. T. A. (2009) · International Journal of Rheumatology · doi:10.1155/2009/286951
“A high frequency of in vitro elevated D8/17 binding to B lymphocytes has been found as a susceptibility marker for developing ARF more than PSRA [7, 8, 24].”
Background
- Authors
- Zabriskie, J. B., Lavenchy, D., Williams, R. C., Fu, S. M., Yeadon, C. A., Fotino, M., & Braun, D. G.
- Affiliations
- Rockefeller University (US)
- University of New Mexico (US)
- Oklahoma Medical Research Foundation (US)
- Royal Victoria Hospital (CA)
- New York Blood Center (US)
- Corresponding author
- Zabriskie, J. B.
- ORCID
- Fu, S. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1985-09
- Volume
- 28
- Issue
- 9
- Pages
- 1047-1051
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2030195453
- Cited by
- 110
- References
- 0
- Citations by year
- 2025: 1 · 2024: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2016: 3 · 2015: 2 · 2013: 3 · 2012: 2
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI 14361)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vasculitis and related conditions
- Keywords
- rheumatic fever, B-cell alloantigens, monoclonal antibodies, B cells, serological diagnosis
- MeSH terms
- Antibodies, Monoclonal, Antibody Specificity, B-Lymphocytes, Clone Cells, Humans, Hybridomas, India, Isoantigens, Rheumatic Fever, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
